RTD

A scientific perspective on the regulatory status of products derived from gene editing

The European Commission’s Scientific Advice Mechanism (SAM) Group of Chief Scientific Advisors has on18 November 2018, published a statement providing ‘a scientific perspective on the regulatory status of products derived from gene editing, and the implications for the GMO Directive’.